Navigation Links
Nebulizer in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

... COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were ... researchers chose PARI products as the exclusive nebulizer systems for recent studies comparing maintenance ... to placebo/tiotropium. The PARI LC Plus nebulizer and PARI PRONEB Ultra compressor were used ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

... once daily for 28 days using an eFlow(R) nebulizer System (PARI Pharma GmbH), a novel, highly ... About PARI Pharma and the eFlow (R) nebulizer System ARIKACE is delivered by an eFlow nebulizer System developed by PARI Pharma GmbH. The ...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

... for L-CsA, delivered via an Investigational eFlow nebulizer System, for the prevention and treatment of ... for administration via an Investigational eFlow nebulizer System without destroying the liposome," stated ... dose of 10mg L-CsA with an Investigational eFlow nebulizer System would give approximately 14 mg L-CsA/week. ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... a customized small droplet Investigational eFlow nebulizer System designed to deliver drugs to the deep ... (MMAD ~ 3.3 microns) Investigational eFlow nebulizer System has similar effects on asthma control, ... when administered via the Investigational eFlow nebulizer System," said Prof. Johannes Wildhaber, principal ...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

... inhalation solution delivered via PARI's LC STAR nebulizer and PRONEB Ultra compressor for the treatment of ... The combination of PARI's LC STAR breath-enhanced nebulizer and PRONEB Ultra compressor provides for a quick ... the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award-winning ...

PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study

... /PRNewswire/ -- An optimized PARI eFlow platform nebulizer will be delivering Alnylam's ALN-RSV01 in a Phase ... . About eFlow eFlow, an electronic, portable nebulizer platform, enables extremely efficient ... vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very ...

PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial

... Va., March 10 /PRNewswire/ -- PARI's LC STAR nebulizer and PRONEB Ultra II compressor are the exclusive ... Equipment. "Our LC STAR is a fine particle nebulizer that enables delivery of aerosols to the smaller ... . The combination of PARI's LC STAR nebulizer and PRONEB Ultra II compressor provides for a ...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

... 26 /PRNewswire/ -- PARI Pharma's eFlow electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent ... that produce the aerosol mist. Compared to other nebulizer systems, eFlow can produce aerosols with a ... inhalation drug development, including nebulizer formulation development and optimization, ...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

... of levofloxacin inhaled solution delivered by an Investigational eFlow nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary ... of MP-376 when administered by inhalation using an Investigational eFlow nebulizer System. All patients were required to be culture positive for P. ...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

... Pseudomonas aeruginosa. Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug ... Nebulizer, developed by PARI Pharma GmbH. eFlow(R) is a quiet portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

... proprietary Fluidosomes technology with the well-established generic drug tobramycin. Utilising synthetic liposomes containing tobramycin, a standard nebulizer delivers the drug directly to the endobronchial sites of infection in cystic fibrosis patients. This may result in prolonged high local drug ...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

... Arikace is delivered by a novel inhalation device, the eFlow(R) Electronic Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications, including liposomal formulations such as Arikace, via a vibrating perforated membrane. ...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

... that provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Hospital-acquired, gram-negative bacterial pneumonia is ... which provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Sources: ...

PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin

... liquid medications via a vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very high density of active ... PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and optimization, CMC, analytics, aerosol ...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... in the United States and Europe. About PARI and the eFlow Electronic nebulizer Aztreonam lysine is delivered through a novel inhalation device, the ... developed by PARI Pharma GmbH. The eFlow is an electronic, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... the United States and Europe. About PARI Pharma and the eFlow Electronic nebulizer Aztreonam lysine for inhalation is delivered by a novel inhalation ... Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference

... optimized to advanced delivery platforms, such as eFlow. Focusing on comprehensive inhalation therapy development, including optimized nebulizer formulations, analytics, and aerosol characterization, PARI Pharma has several clinical development programs ongoing, either partnered or ....
Other Contents
(Date:9/22/2014)... STATION The smell of cut grass in recent ... signalling distress, but new research says the aroma also ... is need for protection, the plant signals the environment ... recognized as a feeding queue for parasitic wasps to ... lay eggs in the pest insect," said Dr. Michael ...
(Date:9/22/2014)... in a plant,s biological clock one that modulates ... , Transcription factors, or genetic switches, drive gene expression ... light, rain, soil quality, or even animals grazing on ... one, called FBH1, that reacts to temperature tweaking ... keeping it on a consistent track. , "Temperature helps ...
(Date:9/22/2014)... YORK CITY (September 22, 2014)The Brain & ... the award of NARSAD Young Investigator Grants ... 200 of the world,s most promising young ... for groundbreaking neurobiological research will seek to ... strategies for psychiatric disorders that affect one ...
Breaking Biology News(10 mins):Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3Genetic switch regulates a plant's internal clock based on temperature 2Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2
(Date:9/23/2014)... 2014 What: Rutgers Presbyterian Church, ... Side that embodies the inclusion and diversity of ... and the Ecological Crisis, a public lecture led ... Emerita of Old Testament at Louisville Presbyterian Seminary. ... that lends insight into current ecological problems, including ...
(Date:9/23/2014)... benefits of preventing a reduction in the rates ... today by the American College of Physicians (ACP). ... Medicaid Primary Care Pay Parity Program: Unless Congress ... Care Will Expire," explains why it is critical ... pediatricians (and their related subspecialists), family physicians, and ...
(Date:9/23/2014)... Singapore (PRWEB) September 23, 2014 ... aesthetic clinics in Singapore and Malaysia providing advanced ... revolutionary BB powder to its impressive skin care ... strengthen the skin’s defences against the evil forces ... a healthy glow simultaneously, this new addition is ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- The ... million in additional funding in scientific trials to ... and clinical studies. The supplemental monies were ... fields, including basic immunology, cardiovascular physiology, neural circuitry, ... Sept. 23. "This funding strategy demonstrates our ...
(Date:9/23/2014)... Karl Klose, professor of biology and a researcher in ... teamed up with researchers at Ruhr University in Bochum, ... Their findings were released this week in an article ... of Sciences . , Cholera is an acute infection ... contaminated with the bacterium Vibrio cholerae . An ...
Breaking Medicine News(10 mins):Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:NIH Adds $10M to Encourage Gender Balance in Clinical Trials 2Health News:UTSA microbiologists discover regulatory thermometer that controls cholera 2
Other TagsOther Tags